The Artemis 2 astronauts remained vigilant while zipping around the far side of the moon last month, on the ready to record ...

Cameras were rolling when Dr. Sandra Lee realized something was wrong. The dermatologist and "Dr. Pimple Popper: Breaking Out" star revealed she suffered a stroke while treating patients at her ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...

Shares of Grail lost more than half their value on Friday, after a key trial of the company’s cancer screener failed to meet its primary objective. The stock’s GRAL plunge reflected the disappointment ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new study identified the symptoms women most commonly ...

HONOLULU (AP) — Muddy floodwaters from severe rains inundated streets, pushed homes off their foundations, swallowed vehicles and prompted evacuation orders for thousands of residents in towns north ...

Please provide your email address to receive an email when new articles are posted on . Men with prostate cancer who received 5 mg twice-daily oxybutynin experienced ...

Flash drives are common for good reason: they're cost-effective storage solutions. Apart from that, they're small, allowing you to carry them almost everywhere. Then, there's the convenience. You plug ...

Forbes contributors publish independent expert analyses and insights. Kim Elsesser covers issues that impact women in the workplace. This voice experience is generated by AI. Learn more. This voice ...

A phase 2 randomized, double-blind trial tested oxybutynin 2.5 mg BID and 5 mg BID versus placebo for six weeks in men on stable ADT with ≥28 weekly hot flashes. Dose-dependent efficacy was observed, ...

Among men with prostate cancer receiving androgen deprivation therapy (ADT), oxybutynin led to significant reductions in hot flash frequency, with the 5-mg twice-daily dose decreasing hot flashes by ...

The drug also treats an overactive bladder. Oxybutynin significantly reduced hot flashes in men receiving prostate cancer hormone therapy. Prostate cancer risk increases with age, but younger men may ...